Selection on genes underlying schizophrenia during human evolutionSeptember 05, 2007Several genes with strong associations to schizophrenia have evolved rapidly due to selection during human evolution, according to new research in the Proceedings of the Royal Society B (Wednesday 5 September 2007). Researchers found a higher prevalence of the influence of so-called positive selection on genes or gene regions known to be associated with the disorder than a comparable control set of non-associated genes, functioning in similar neuronal processes. This is consistent with the theory that positive selection may play a role in the persistence of schizophrenia at a frequency of one per cent in human populations around the world, despite its strong effects on reproductive fitness and its high heritability from generation-to-generation. It also provides genetic evidence consistent with the long-standing theory that schizophrenia represents, in part, a maladaptive by-product of adaptive changes during human evolution - possibly to do with aspects of creativity and human cognition. "The world-wide presence of this disorder at an appreciable frequency, despite its impact on human health and reproductive fitness, is somewhat of a paradox," said Dr Steve Dorus from the University of Bath, who worked with Dr Bernard Crespi from Simon Fraser University (Canada) and Dr Kyle Summers from East Carolina University (USA) on the research. "This may be explained by the existing theory that the condition represents, in part, a by-product of adaptive changes during human evolution. "Our finding that positive evolutionary processes have impacted genes underlying the disorder is consistent with this idea. "However, the selective forces influencing the evolution of these genes remain unknown. "Given the complex genetic nature of the condition, selection may be mediated by a diverse array of neurodevelopmental, neurophysiological and psychological mechanisms. "Schizophrenia has also been associated with creativity throughout recorded history, but whether this link has a genetic basis is certainly not yet clear." The researchers analysed the molecular evolution of the 76 genes that have the strongest genetic association with the disorder. They surveyed human polymorphisms - discrete changes in the human genome that vary between individuals - for very recent selective events within specific human populations. They also compared genes between mammalian species to identify selection on primate lineages salient to the evolution of humans and the disorder. The research identified evidence for positive selection on a variety of genes, including three genes that have the best functional or reproducible associations with the disorder: disrupted in schizophrenia (DISC1), dystrobrevin-binding protein 1 (DTNBP1) and neuregulin 1 (NRG1). "For the first time it is possible to complement our genetic understanding of the disorder with substantial evolutionary and comparative genomic analyses," said Dr Dorus. "Decades of intensive research, using association and inheritance studies between affected and non-affected siblings, has resulted in a much clearer understanding of the genetic basis of the disorder. "Hopefully, a better understanding of the evolution of the substrates underlying the disease will assist in characterizing how they are dysregulated in the disorder. "Understanding the impact of positive selection may also help refine hypotheses concerning genetic links between schizophrenia and aspects of human creativity and cognition." The research was funded in part by the Natural Sciences and Engineering Research Council of Canada, East Carolina University and the National Institutes of Health. The University of Bath |
|||||||||||||||||||||
| Related Schizophrenia Current Events and Schizophrenia News Articles Schizophrenia gene's role may be broader, more potent, than thought UCSF scientists studying nerve cells in fruit flies have uncovered a new function for a gene whose human equivalent may play a critical role in schizophrenia. Full recovery now possible for an 'untreatable' mental illness Patients coping with the chaos and misery of Borderline Personality Disorder now have reason for strong confidence in making major life changes through a new treatment, Schema Therapy. Immune system activated in schizophrenia Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system. Why can't chimps speak? If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not? Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation. Testicular tumors may explain why some diseases are more common in children of older fathers A rare form of testicular tumour has provided scientists with new insights into how genetic changes (mutations) arise in our children. CSHL-led team discovers rare mutation dramatically increasing schizophrenia risk An international team of researchers led by geneticist Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL), has identified a mutation on human chromosome 16 that substantially increases risk for schizophrenia. Faulty 'wiring' in the brain triggers onset of schizophrenia A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia. General anesthetics lead to learning disabilities in animal models Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature. More Schizophrenia Current Events and Schizophrenia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||